APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.
about
Breaking bad: The mutagenic effect of DNA repairAID/APOBEC deaminases and cancerMolecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancerAPOBEC3B, a molecular driver of mutagenesis in human cancers.Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulationRepair of naturally occurring mismatches can induce mutations in flanking DNA.Association between targeted somatic mutation (TSM) signatures and HGS-OvCa progressionIdentification of genomic alterations in pancreatic cancer using array-based comparative genomic hybridization.Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3BAPOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation.Characterization of the Catalytic Domain of Human APOBEC3B and the Critical Structural Role for a Conserved Methionine.APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity.TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancerMutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B.Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma.APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myelomaAID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer.An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancersAPOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer.DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B.Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women.The PKC/NF-κB signaling pathway induces APOBEC3B expression in multiple human cancers.Progressive APOBEC3B mRNA expression in distant breast cancer metastases.Transcriptional regulation of APOBEC3 antiviral immunity through the CBF-β/RUNX axis.Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain.A common variant in MTHFR influences response to chemoradiotherapy and recurrence of rectal cancer.Integrative genomic analysis reveals functional diversification of APOBEC gene family in breast cancer.APOBEC3A damages the cellular genome during DNA replicationIndependent validation of a mathematical genomic model for survival of glioma patients.Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.Activation-Induced Cytidine Deaminase Links Ovulation-Induced Inflammation and Serous CarcinogenesisThe DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis.The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.APOBEC3B expression in human leptomeninges and meningiomas.Risks at the DNA Replication Fork: Effects upon Carcinogenesis and Tumor HeterogeneityMechanisms of base substitution mutagenesis in cancer genomes.A Novel Regulator of Activation-Induced Cytidine Deaminase/APOBECs in Immunity and Cancer: Schrödinger's CATalytic Pocket.DNA damage repair machinery and HIV escape from innate immune sensing.Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV VifElevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells.
P2860
Q26827700-EE0086BC-B55F-48B8-8E9F-033849252BD5Q28085553-8E044F61-B4C0-4CD3-A0D2-44A92D70CA6EQ28088790-BADB1927-1C46-4F67-8EF0-12361247DF95Q33743603-D73721D1-1F0F-4EB6-A1F5-1E4AF335CF53Q33878087-D2FC4C62-2EB6-4647-84E4-6C75C2A3B884Q34420649-B2CA8F4F-9A77-4B7B-9B9C-68282CF60619Q34536160-244CC347-706B-4BD8-BBBA-45008693B9E0Q34682133-6DA77073-A0F0-499F-A82C-2B6DBE62CE3EQ34782173-4125BB56-6C87-45B2-95EC-890001BF5951Q35156922-A7944A7D-1BFC-407B-A727-20997A24557EQ35747955-2529F59A-C20D-4DDB-8AC5-225470645DAEQ35836909-8690B8AE-4C82-4025-B7CD-917848FAFD15Q35961836-20DE5700-7FAA-45C2-8840-5B5BD4B51731Q36013147-45B374EB-5CA1-42F3-BCB0-4006F48BA324Q36054401-776C2A04-B37F-406E-BA63-EEC733791F0BQ36055752-768F2AEF-03D3-423C-974F-877FEDE2B16FQ36104522-2D2F2EB4-A59C-4E57-BC71-CAC05C98496AQ36123927-1BBDE7EE-DF20-4875-B717-DC4292B17043Q36133842-B0FEFC14-C772-42EF-A3D2-D0FA13A648B3Q36184715-931B2390-0F30-4B70-BE48-26CBA15CDCA5Q36225122-283BD2CE-2E76-4491-A232-8D7950DABCAFQ36244879-8820DF96-0EA6-458B-A9D2-7BE79297CC69Q36265144-067540C7-DBA7-4536-8269-CA0BD3B21499Q36276957-D22B373F-DE3E-4836-954C-4E96A41C8809Q36301232-3ACFF648-12DB-40F0-B2C9-5365EA596B6BQ36309438-65F24494-E89C-425B-AB3D-409D569E9DF8Q36385674-48796A57-0A5B-4DB9-95E7-26D941C27FF0Q36956935-FE082838-DAE3-4E85-A3D3-C77628AED43DQ37077427-7612BA12-F843-43B4-B30E-9D0873309CFDQ37091342-C59661CE-CE35-4567-85DA-6FB38D66E1E5Q37217999-A3CD4C0E-9C02-4AAE-A429-340D419E4B73Q37281847-074C821B-CCA5-48E3-99BB-CBC320F5465FQ37321593-F9D535BB-6A70-479C-A835-778755C2EF8AQ37581824-C4C55665-2F29-4F4C-8C48-5214B68C9022Q37628288-ECABDDB1-70DE-428C-BDA6-D51A98288B9FQ37689834-25DFABF9-B554-46A1-8F2F-72E54EB507A7Q37739072-56DABDB4-0CE1-4384-99C2-4807BE11A125Q38209320-C0F7B8B9-CDD5-4637-AD04-7F6AE4663826Q38261732-E329923C-958D-46EA-8684-2DFC991598EAQ38702556-58D643FD-B9B8-4908-B081-9E73E0CAAA4B
P2860
APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.
@en
APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.
@nl
type
label
APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.
@en
APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.
@nl
prefLabel
APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.
@en
APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.
@nl
P2093
P2860
P50
P1433
P1476
APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma
@en
P2093
Ann L Oberg
Anurag Rathore
Brandon Leonard
Craig April
David Bentley
Debra A Bell
Elizabeth M Swisher
Ellen L Goode
Emily K Law
Hugues Sicotte
P2860
P304
P356
10.1158/0008-5472.CAN-13-1753
P407
P50
P577
2013-10-23T00:00:00Z